These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 6140441
1. Development of a pertussis component vaccine in Japan. Sato Y, Kimura M, Fukumi H. Lancet; 1984 Jan 21; 1(8369):122-6. PubMed ID: 6140441 [Abstract] [Full Text] [Related]
2. Comparative toxicity, protective, histamine sensitizing and leucocytosis promoting activities in mice of Bordetella pertussis culture fluid, bacterial cells and cell extracts. Megret F, Fournier JM, Alouf JE. Med Microbiol Immunol; 1984 Jan 21; 173(4):225-32. PubMed ID: 6096686 [Abstract] [Full Text] [Related]
3. Further characterization of Japanese acellular pertussis vaccine prepared in 1988 by 6 Japanese manufacturers. Sato Y, Sato H. Tokai J Exp Clin Med; 1988 Jan 21; 13 Suppl():79-88. PubMed ID: 2908530 [Abstract] [Full Text] [Related]
4. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. N Engl J Med; 1996 Feb 08; 334(6):349-55. PubMed ID: 8538705 [Abstract] [Full Text] [Related]
5. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, Ciofi degli Atti ML, Giammanco A, Panei P, Blackwelder WC, Klein DL, Wassilak SG. N Engl J Med; 1996 Feb 08; 334(6):341-8. PubMed ID: 8538704 [Abstract] [Full Text] [Related]
6. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children. Ashworth LA, Robinson A, Irons LI, Morgan CP, Isaacs D. Lancet; 1983 Oct 15; 2(8355):878-81. PubMed ID: 6137697 [Abstract] [Full Text] [Related]
7. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis. Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB. Clin Infect Dis; 1999 Mar 15; 28(3):552-9. PubMed ID: 10194077 [Abstract] [Full Text] [Related]
8. [The immunological basis of the administration of DTP-polio vaccine]. Cohen H. Verh K Acad Geneeskd Belg; 2000 Mar 15; 62(4):245-67. PubMed ID: 11004905 [Abstract] [Full Text] [Related]
10. Characterization and clinical study on the acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous hemagglutinin. Ginnaga A, Morokuma K, Aihara K, Sakou M, Imaizumi A, Suzuki Y, Sato H, Sato Y, Ueda K, Kuno-Sakai H. Tokai J Exp Clin Med; 1988 Apr 15; 13 Suppl():59-69. PubMed ID: 2908528 [Abstract] [Full Text] [Related]
11. Pertussis immunization of infants using a new combined DTP-polio vaccine. Drucker J, Schatzmayr H, Grenier B, Ajjan N, Peyron L, Roumiantzeff M. Dev Biol Stand; 1985 Apr 15; 61():309-13. PubMed ID: 2872119 [Abstract] [Full Text] [Related]
12. Specific IgE antibodies to Bordetella pertussis after immunisation in infancy. Haus M, Weinberg EG, Malherbe D. Lancet; 1988 Mar 26; 1(8587):711. PubMed ID: 2895248 [No Abstract] [Full Text] [Related]
13. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis. Ausiello CM, Urbani F, La Sala A, Lande R, Piscitelli A, Cassone A. Dev Biol Stand; 1997 Mar 26; 89():315-20. PubMed ID: 9272365 [Abstract] [Full Text] [Related]
14. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine. Taranger J, Trollfors B, Bergfors E, Knutsson N, Lagergård T, Schneerson R, Robbins JB. Pediatrics; 2001 Dec 26; 108(6):E115. PubMed ID: 11731642 [Abstract] [Full Text] [Related]
15. Dot immunoassay for the simultaneous determination of postvaccination immunity against pertussis, diphtheria, and tetanus. Khramtsov P, Bochkova M, Timganova V, Zamorina S, Rayev M. Anal Bioanal Chem; 2017 Jun 26; 409(15):3831-3842. PubMed ID: 28374129 [Abstract] [Full Text] [Related]
16. Japanese clinical trials with Takeda acellular pertussis vaccine. Kuno-Sakai H, Kimura M, Ozaki K, Isomura S, Kamiya H, Nii R, Kato T, Horiuchi K, Syukuda Y, Fujita I. Tokai J Exp Clin Med; 1988 Jun 26; 13 Suppl():15-9. PubMed ID: 2908519 [Abstract] [Full Text] [Related]
17. [Antibody response to the fractionated administration of the 2d or 3d basic vaccination injection with a mixed vaccine against diphtheria, tetanus and pertussis]. Vodicková M, Svandová E. Cesk Pediatr; 1986 Jun 26; 41(6):321-3. PubMed ID: 2872973 [No Abstract] [Full Text] [Related]
18. Results with a new DTP vaccine in Japan. Kimura M, Hikino N. Dev Biol Stand; 1985 Jun 26; 61():545-61. PubMed ID: 2872131 [Abstract] [Full Text] [Related]
19. Experiences with a new combined vaccine against B. parapertussis, Diphtheria, tetanus and B. pertussis employed in a field trial in Prague 10. Burianová-Vysoká B, Burian V, Kríz B, Pellar T, Hellerová J, Rádkovský J. Prog Immunobiol Stand; 1967 Jun 26; 3():335-40. PubMed ID: 4314432 [No Abstract] [Full Text] [Related]
20. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A, Stage III Working Group. Pediatrics; 2001 Nov 26; 108(5):E81. PubMed ID: 11694665 [Abstract] [Full Text] [Related] Page: [Next] [New Search]